Category Archives: MS Treatment

Vitamin D Helps Predict Multiple Sclerosis Activity and Progression A New Study Finds Please like, subscribe, comment and share! ORIGINAL ARTICLE http://archneur.jamanetwork.com/article.aspx?articleid=1815002 (MS) is a common cause of neurological disability in young adults.... By: Lifestyle Medicine … Continue reading →

Biogen Idec Inc. said Monday that its multiple sclerosis pill, Tecfidera, has been approved by regulators as a first-line treatment for people with the most common form of MS in Europe. The drug got US approval last March. In November, European officials said that Tecfidera would have 10 years of regulatory data exclusivity if the drug got final approval. (The company has equivalent protection in the US.) In a statement included in Mondays press release, Biogen Idec chief executive George A. Scangos said: Tecfidera exemplifies our commitment to deliver innovative therapies that help people living with serious diseases. We already have seen Tecfideras significant impact on transforming the standard of care for MS where it is available and are excited to quickly bring its benefits to patients in the EU as well. Original post: Biogen Idec MS drug approved in the European Union … Continue reading →

New information that could lead to improved treatment of multiple sclerosis (MS) has been uncovered by Victoria University of Wellington scientists. A study carried out at Victoria, and recently published online in the international scientific journal PLOS ONE, holds promise for patients suffering from secondary progressive MS, an advanced form of the disease, which causes nerve degeneration leading to impaired vision and coordination, and eventually, paralysis. The study focused on understanding how a new MS drug, MIS416, developed by the New Zealand biotech company Innate Immunotherapeutics, is able to help patients with secondary progressive MS, a form of MS with few effective treatments. The team of scientists includes Dr Anne La Flamme, an Associate Professor in Victorias School of Biological Sciences and head of the MS Research Programme at the Malaghan Institute of Medical Research, PhD student Madeleine White, and Dr Gill Webster from Innate Immunotherapeutics. "We know this drug works, but we are not sure why. This study has helped us understand the pathways that are driving the disease and how the medication alters the immune system, giving us a better idea of why MIS416 works as well as insight into how to treat patients and predict who will … Continue reading →

Multiple Sclerosis Treatment: Tecfidera Beginning Tecfidera, a personal story of how I am managing potential side effects from the MS medication. Follow my blog http://www.MSsymptoms.me, educating on MS t... By: Melissa Cook … Continue reading →

By Rod Minchin The New Zealand mother who lost a UK High Court fight to stop her eight-year-old son receiving treatment for cancer says he's looking forward to going back to school. Sally Roberts says Neon is recovering and his spirits are up, and he will go back to school when he's strong enough after the completion of radiotherapy. "I'm incredibly proud of Neon and he's handled everything incredibly well and doing OK," Ms Roberts told BBC Five Live. "Now that the treatment's finished he's making a recovery. "He's not quite as lively as his twin sister but he's an incredible little boy and his spirits are up and he's handled everything so well. I'm so proud." Ms Roberts, 38, lost a legal battle to stop her son receiving radiotherapy treatment, which she believed would cause Neon to suffer long-term harm, after the removal of the tumour in October 2012. Doctors argued that her son would die within three months if he did not receive the treatment. Following the ruling, Ms Roberts, who was then living in Devon in southwest England, and her son disappeared but were found four days later. She says Neon had no idea of the legal … Continue reading →

Contact Information Available for logged-in reporters only Newswise Global research overseen by and conducted at the Wayne State University School of Medicine will immediately change the treatment regimen of millions of multiple sclerosis patients around the world. The U.S. Food and Drug Administration Tuesday approved a new drug application that calls for the injection of Copaxone at a higher dose, but fewer times per week for patients with relapsing forms of multiple sclerosis. The availability of three-times-a-week Copaxone 40 mg/mL is a significant advancement for patients as they now have the option of effective and safe treatment with the drug, while reducing the number of injections by 60 percent, said Omar Khan, M.D., professor and chair of neurology at the Wayne State University School of Medicine. Patients in the United States can now benefit from an improved dosing regimen without compromising the known benefits of Copaxone. The study was published in the Annals of Neurology, a leading clinical neuroscience journal and the official publication of the American Neurological Association. Dr. Khan, a member of the Wayne State University Physician Group, is the global principal investigator of the Glatiramer Acetate Low-Frequency Administration, or GALA, study. The study investigated a new dose … Continue reading →

Botany Downs woman Genevieve Forde claims she couldnt afford treatment for her kittens severely infected and ruptured eye, leaving the kitten half-blind as a result. Ms Forde was convicted today in the Manukau District Court for ill-treating an animal. She given 60 hours community service and ordered to pay reparations of $2250. The cat was forfeited to the SPCA. The story began on Friday 8 March 2013 when an SPCA Auckland Inspector was called to the Great South Vets veterinary clinic to attend to a four-month-old, black-and-white, female kitten that had a severely diseased right eye. The Defendant had brought the kitten to the clinic to be desexed but staff refused to perform the operation unless the eye was also treated. The Defendant was given the option of surrendering the kitten to the SPCA if she could not afford the treatment, but instead simply left the kitten at the clinic. The kittens right eye had a large, dry mass protruding from it and was oozing thick, yellow fluid. The kitten was hunched and pulled away from any attempts to touch her head, indicating pain and distress. Following unsuccessful attempts to contact the Defendant, the kitten was seized and transported to … Continue reading →

Denver, CO (PRWEB) January 29, 2014 According to the review on http://www.SclerosisTreatment.com, the Multiple Sclerosis Natural Treatment is a complex program that was created by Dr. Gary M. Levin, a health consultant and American surgeon. Levin claims that after years of study and research, he was able to achieve the impressive method that can help all sufferers feel better and overcome MS easier. To read the full report, go to: http://www.sclerosistreatment.com/2013/02/multiple-sclerosis-natural-treatment.html. Actually, Levin says that his method is so successful only because it addresses the real cause of the disease. The MS Natural Treatment review indicates that MS is in fact caused by an overactive immune system. From this point of view, Levin says that the only effective way to stop this disease is by repairing the immune system, which has been damaged. For that, the author of this program provides a series of natural techniques in his guide. The Multiple Sclerosis Natural Treatment program is available in a simple to download eBook that anyone may access. The eBook introduces sufferers to a series of natural remedies which may prove a great efficiency in the cure of multiple sclerosis. The review indicates that Levin talks about the existence of some … Continue reading →

By Dow Jones Business News, January 29, 2014, 07:08:00 AM EDT By Ben Fox Rubin Biogen Idec Inc. ( BIIB ) on Wednesday said its fourth-quarter profit grew 57%, as sales of its multiple-sclerosis treatment Tecfidera continued to boost the biotechnology company's revenue. For the new year, the company projected adjusted earnings of $11.00 to $11.20 a share and revenue growth of 22% to 25% . Analysts polled by Thomson Reuters expected $11.63 a share in profit and revenue growth of 21%. Biogen recently launched Tecfidera, a pill for multiple sclerosis that analysts expect to steal significant market share from the injectable drugs that now dominate the market. The drug has had brisk early adoption from patients seeking easier-to-take drugs, despite having been approved after two rival oral drugs made by Biogen competitors. Biogen is aiming to become the dominant maker of MS treatments, a group of drugs that command high prices and that patients typically take for years. The company reported a profit of $457.3 million, or $1.92 a share, up from $292.1 million, or $1.23 a share, a year earlier. Excluding amortization and other items, per-share earnings grew to $2.34 from $1.40. Revenue jumped 39% to $1.97 billion. … Continue reading →

Denver, Colorado (PRWEB) January 28, 2014 Daily Gossip Magazine reveals in its Natural Multiple Sclerosis Treatment review that this program was actually created by Dr. Gary M Levin, an appreciated surgeon and health expert. To read more about Dr. Gary M. Levin's natural treatment for Multiple sclerosis visit the official website at: http://www.dailygossip.org/natural-multiple-sclerosis-treatment-review-7356 Levin says that even though multiple sclerosis can be a very discouraging condition, patients should know that a cure can be achieved for this disease. According to the author of Natural Multiple Sclerosis program, the reason why doctors cannot cure multiple sclerosis is actually linked to the fact that they dont understand the real cause of the disease. Dr. Gary claims that multiple sclerosis is in fact an autoimmune condition, caused by the overactive immune system. According to the Natural Multiple Sclerosis Treatment review, Gary Levin goes further to explain that the overactive immune system actually is the real problem that sufferers need to deal with in order to achieve a cure. Levins method to cure multiple sclerosis is detailed by the author in his guide, which naturally focuses on eliminating the cause of the disease. Levin says that strengthening the immune system will help sufferers improve … Continue reading →